Publication | Open Access
A Pilot Study of the Telomerase Inhibitor Imetelstat for Myelofibrosis
317
Citations
27
References
2015
Year
Imetelstat was found to be active in patients with myelofibrosis but also had the potential to cause clinically significant myelosuppression. (Funded by Geron; ClinicalTrials.gov number, NCT01731951.).
| Year | Citations | |
|---|---|---|
Page 1
Page 1